|Mr. William J. Gastle||Founder & Exec. Chairman||197.75k||N/A||N/A|
|Mr. Cameron Groome||Pres, CEO & Director||N/A||N/A||N/A|
|Mr. Philip Casselli||Sr. VP of Sales, Bus. Devel. and Marketing||179.54k||N/A||N/A|
|Mr. Vaughn C. Embro-Pantalony||Exec. Director||221.5k||N/A||N/A|
|Mr. Kevin J. Cassidy||VP of Biopharmaceuticals||150k||N/A||N/A|
Microbix Biosystems Inc. develops, manufactures, and sells biological products and technologies in North America, Europe, and internationally. The company manufactures and sells cell culture-based biological products, as well as infectious disease antigens. It offers infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry; controls for molecular diagnostic assays; basic and applied research in virology, microbiology, cell biology, molecular biology, immunology, and pathology; as controls and calibrators for a range of medical devices; and for vaccine and antiviral research and development. In addition, the company manufactures inactivated viral antigen detection proficiency testing samples; and unassayed control reagents for in vitro molecular diagnostic assays. Its pipeline of technologies and products include LumiSort semen sexing technology for the livestock industries; Kinlytic, a thrombolytic drug for the treatment of life-threatening pulmonary embolism and clot obstructed intravenous catheters; and VIRUSMAX, a technology used to enhance influenza vaccine manufacturing yields. The company offers products for human health applications in the diagnostic and animal reproduction markets. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.
Microbix Biosystems Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.